The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of breast cancer genomic subtypes that associate with prognosis and response to therapy in retrospective analyses.
D. Rhodes
Employment or Leadership Position - Compendia Bioscience
Consultant or Advisory Role - Compendia Bioscience
Stock Ownership - Compendia Bioscience
S. A. Tomlins
No relevant relationships to disclose
J. K. Freshley
Employment or Leadership Position - Compendia Bioscience
Stock Ownership - Compendia Bioscience
P. Wyngaard
Employment or Leadership Position - Compendia Bioscience
Stock Ownership - Compendia Bioscience
S. Sadis
Employment or Leadership Position - Compendia Bioscience
K. Oades
Employment or Leadership Position - AltheaDx
S. Chattopadhyay
Employment or Leadership Position - AltheaDx
H. Kim
Employment or Leadership Position - AltheaDx
L. Vo
Employment or Leadership Position - AltheaDx
D. Telford
Employment or Leadership Position - AltheaDx
Y. Wang
Employment or Leadership Position - AltheaDx
B. Lee
Employment or Leadership Position - AltheaDx
J. Monforte
Employment or Leadership Position - AltheaDx